Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2008
03/11/2008US7341727 M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
03/11/2008US7341726 Modified HCV peptide immunogens
03/11/2008US7341725 Structural proteins of fish pancreatic disease virus and uses thereof
03/11/2008US7341723 Nucleic acid construct encoding a processing component derived from the N-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide
03/11/2008US7341722 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
03/11/2008US7341719 Myoblast therapy for cosmetic treatment
03/11/2008US7341718 Neuronal gene transfer of adenovirus and herpes virus vectors
03/11/2008CA2331764C Polyketides and their synthesis
03/11/2008CA2300358C Novel phytase
03/11/2008CA2270396C Cationic reagents for transfection
03/11/2008CA2252048C Detection probes, kits and assays
03/11/2008CA2203372C Human scf, a splice variant thereof, its pharmaceutical use
03/11/2008CA2169758C Nucleic acid probes to ureaplasma
03/11/2008CA2126091C Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides
03/08/2008WO2008039173A2 Methods and compositions for inhibiting cell death or enhancing cell proliferation
03/08/2008CA2622504A1 Methods and compositions for inhibiting cell death or enhancing cel proliferation
03/06/2008WO2008028162A2 Methods of screening agents for activity using teleosts
03/06/2008WO2008028121A1 Plant transformation without selection
03/06/2008WO2008028119A2 Methods for rapidly transforming monocots
03/06/2008WO2008028115A2 Methods for producing transgenic plants
03/06/2008WO2008028085A2 Modulation of mlck-l expression and uses thereof
03/06/2008WO2008028002A1 Increasing nadph-dependent products
03/06/2008WO2008027986A2 Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
03/06/2008WO2008027855A2 Compositions and methods for modulating mtor signaling
03/06/2008WO2008027742A1 Beta-alanine/alpha-ketoglutarate aminotransferase for 3-hydroxypropionic acid production
03/06/2008WO2008027592A2 Phased small rnas
03/06/2008WO2008027558A2 Iterative nucleic acid assembly using activation of vector-encoded traits
03/06/2008WO2008027452A2 Self-assembling oligonucleotides and methods
03/06/2008WO2008027394A2 Constructs for enhancing immune responses
03/06/2008WO2008027384A1 Methods and compositions for transposon-mediated transgenesis
03/06/2008WO2008026946A2 Compositions and methods for the treatment and prevention of neoplastic disorders
03/06/2008WO2008026719A1 Nucleic acid amplification method
03/06/2008WO2008026698A1 Method for production of l-glutamic acid
03/06/2008WO2008026619A1 Process for the production of 3-hydroxyalkanoic acid copolymers
03/06/2008WO2008026584A1 METHOD FOR EVALUATING COMPOUND USING PKC-iota
03/06/2008WO2008026582A1 Dna fragment used in the form attached to 5'-terminus of primer for use in amplification reaction of nucleic acid, and use thereof
03/06/2008WO2008026340A1 Method of predicting metastasis of oral cavity cancer into cervical lymph node and diagnosis kit to be used in the prediction
03/06/2008WO2008026309A1 Novel microorganism capable of degrading diphenylarsinic acid
03/06/2008WO2008026075A2 Treatment of intracellular bacterial infections with a protein kinase inhibitor or an as160 polypeptide activator
03/06/2008WO2008026015A2 Liposomally encapsulated hybrid adenovirus-semliki forest virus (sfv) vectors carrying rnai constructs and therapeutic genes for use against cancer targets and other diseases
03/06/2008WO2008025711A2 Method for increasing resistance to pathogens in transgenic plants
03/06/2008WO2008025558A2 Affinity marker comprising a first and a second tag and its use
03/06/2008WO2008025528A1 Method for the production of conjugates of insulin-like growth factor-i and poly(ethylene glycol)
03/06/2008WO2008025527A1 Method for the production of insulin-like growth factor-i
03/06/2008WO2008025516A2 Tnf superfamily fusion proteins
03/06/2008WO2008025164A1 Family 6 cellulases with increased thermostability, thermophilicity, and alkalophilicity
03/06/2008WO2008025163A1 Compositions and methods for modulating ampa receptor-mediated excitotoxicity
03/06/2008WO2008025152A1 Antibacterial agents
03/06/2008WO2008025097A1 Salt tolerant plants
03/06/2008WO2008025093A1 Whole genome based genetic evaluation and selection process
03/06/2008WO2008025069A1 Methods of modulating cellular activity and compositions therefor
03/06/2008WO2008006458A3 Epitope-tag for surface-expressed t-cell receptor proteins, uses thereof and method of selecting host cells expressing them
03/06/2008WO2008005985A3 Insulin-like growth factor-1 receptor antagonists
03/06/2008WO2007147143A3 Rna interference mediated inhibition of 11 beta-hydroxysteroid dehydrogenase-1 (11 beta-hsd-1) gene expression using short interfering nucleic acid (sina)
03/06/2008WO2007146953A3 Compositions and methods for sirna inhibition of angiogenesis
03/06/2008WO2007141111A3 Process for production of a l-lysine containing feed additive
03/06/2008WO2007139943A3 Therapeutic drug combinations and delivery systems comprising c-raf kinase antisense polynucleotides for treating ocular diseases and disorders
03/06/2008WO2007138070A3 Plants with modulated expression of extensin receptor-like kinase having enhanced yield-related traits and a method for making the same
03/06/2008WO2007128755A3 P15 hairpin constructs and use
03/06/2008WO2007124751A3 An animal model and a method for producing an animal model
03/06/2008WO2007119011A3 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family
03/06/2008WO2007115201A3 Polypeptides having endoglucanase activity and polynucleotides encoding same
03/06/2008WO2007109749A3 Methods for preventing and treating amyloidogenic diseases
03/06/2008WO2007106435A3 Cleavable vaccines compositions and methods of making and using the same
03/06/2008WO2007104792A3 Recombinant adenoviruses based on serotype 26 and 48, and use thereof
03/06/2008WO2007103876A3 Cancer therapeutic
03/06/2008WO2007100607A3 Immunogenic peptides and methods of use
03/06/2008WO2007089688A3 Na/k-atpase ligand
03/06/2008WO2007084922A3 Compositions and methods for humanization and optimization of n-glycans in plants
03/06/2008WO2007082269A3 Epsp synthase enzyme domains conferring glyphosate resistance
03/06/2008WO2007062101A3 Intraocular pressure-regulated early genes and uses thereof
03/06/2008WO2006122971A3 Treatment of disease using an improved regulated expression system
03/06/2008WO2006113709A3 Plant promoters, terminators, genes, vectors and related transformed plants
03/06/2008WO2006089264A8 Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli
03/06/2008WO2006050379A3 Modulation of serotonin neurons involving the pet-1 transcriptional control region
03/06/2008WO2003076568A3 Immunotherapeutics for biodefense
03/06/2008US20080060100 Polypeptide Having 5 Fatty Acid Desaturating Activity, Polynucleotide Coding for the Polypeptide, and Use Thereof
03/06/2008US20080060099 Cell Cycle Nucleic Acids, Polypeptides and Uses Thereof
03/06/2008US20080060098 Expression vector comprising nucleotide sequences coding transcription factors for generation of drought, freeze and salinity resistant plants
03/06/2008US20080060097 Expression vector comprising nucleotide sequences coding transcription factors for generation of drought, freeze and salinity resistant plants
03/06/2008US20080060096 Using transgenic animals as biorecators for carotenoids; enhancing nutrient quality of food
03/06/2008US20080060093 Transgenic plant comprising vector coding preferential heterologous gene sequences; improving exogenous gene expression in crop plants
03/06/2008US20080060092 Humanized glycoproteins isolated from plant bioreactors
03/06/2008US20080060091 Method of Gene Introduction in In-Vivo Spermatogenic Cell
03/06/2008US20080060090 Transgenic Mice Inducing Alzheimer's Disease Expressing Mutant Betactf99
03/06/2008US20080060089 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom
03/06/2008US20080060087 Modified Cells and Methods of Using Same
03/06/2008US20080058510 Altering lignin and wood density
03/06/2008US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders
03/06/2008US20080058433 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
03/06/2008US20080058430 Method For Selecting Allosteric Regulators Of Class III G Protein-Coupled Receptors
03/06/2008US20080058279 Such as 3-[4-(2-Octadec-9-enyloxycarbonyl-ethylamino)-butylamino]-propionic acid octadec-9-enyl ester dihydrochloride salt; use with vectors for in vivo transfection
03/06/2008US20080058278 Reduce oxygen toxicity in lung diseases, dysplasia in premature infants; plasmid for coding sequence
03/06/2008US20080058275 Rna Interferases And Methods Of Use Thereof
03/06/2008US20080058271 Dtection of autoantigen; diagnosis, therapy of autoimmune disease
03/06/2008US20080058267 Combinatorial therapy; genetic engineered protein; therapy for autoimmune diaeses; anticancer agents
03/06/2008US20080058265 Methods and compositions for activated protein c with reduced anti-coagulant properties
03/06/2008US20080058263 Polypeptides that binds to cellular receptors; animal growth regukators
03/06/2008US20080058261 Protease susceptibility II
03/06/2008US20080058258 Growth Factor
1 ... 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 ... 4023